94 related articles for article (PubMed ID: 19709164)
1. A meta-analysis on the association of HER-2 overexpression with prognosis in human osteosarcoma.
Li YG; Geng X
Eur J Cancer Care (Engl); 2010 May; 19(3):313-6. PubMed ID: 19709164
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of TP53 tumor suppressor gene expression and mutations in human osteosarcoma: a meta-analysis.
Pakos EE; Kyzas PA; Ioannidis JP
Clin Cancer Res; 2004 Sep; 10(18 Pt 1):6208-14. PubMed ID: 15448009
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of P-glycoprotein, HER-2/ErbB-2, p53, and Bcl-2 in primary tumor and metachronous lung metastases in patients with high-grade osteosarcoma.
Ferrari S; Bertoni F; Zanella L; Setola E; Bacchini P; Alberghini M; Versari M; Bacci G
Cancer; 2004 May; 100(9):1936-42. PubMed ID: 15112275
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathologic analysis of HER-2/neu immunoexpression among various histologic subtypes and grades of osteosarcoma.
Kilpatrick SE; Geisinger KR; King TS; Sciarrotta J; Ward WG; Gold SH; Bos GD
Mod Pathol; 2001 Dec; 14(12):1277-83. PubMed ID: 11743051
[TBL] [Abstract][Full Text] [Related]
5. The association of P-glycoprotein with response to chemotherapy and clinical outcome in patients with osteosarcoma. A meta-analysis.
Pakos EE; Ioannidis JP
Cancer; 2003 Aug; 98(3):581-9. PubMed ID: 12879476
[TBL] [Abstract][Full Text] [Related]
6. Expression of platelet-derived growth factor-alpha receptor in human osteosarcoma is not a predictor of outcome.
Sulzbacher I; Birner P; Dominkus M; Pichlhofer B; Mazal PR
Pathology; 2010 Dec; 42(7):664-8. PubMed ID: 21080877
[TBL] [Abstract][Full Text] [Related]
7. A meta-analysis on the interaction between HER-2 expression and response to endocrine treatment in advanced breast cancer.
De Laurentiis M; Arpino G; Massarelli E; Ruggiero A; Carlomagno C; Ciardiello F; Tortora G; D'Agostino D; Caputo F; Cancello G; Montagna E; Malorni L; Zinno L; Lauria R; Bianco AR; De Placido S
Clin Cancer Res; 2005 Jul; 11(13):4741-8. PubMed ID: 16000569
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of hypoxia-inducible factor-1alpha in human osteosarcoma: correlation with clinicopathological parameters and survival outcome.
Yang QC; Zeng BF; Dong Y; Shi ZM; Jiang ZM; Huang J
Jpn J Clin Oncol; 2007 Feb; 37(2):127-34. PubMed ID: 17237146
[TBL] [Abstract][Full Text] [Related]
9. ErbB-2 expression is correlated with poor prognosis for patients with osteosarcoma.
Onda M; Matsuda S; Higaki S; Iijima T; Fukushima J; Yokokura A; Kojima T; Horiuchi H; Kurokawa T; Yamamoto T
Cancer; 1996 Jan; 77(1):71-8. PubMed ID: 8630943
[TBL] [Abstract][Full Text] [Related]
10. C-erbB-2 expression and prognostic significance in osteosarcoma.
Yalçin B; Gedikoğlu G; Kutluk T; Varan A; Akyüz C; Büyükpamukçu M
Pediatr Blood Cancer; 2008 Aug; 51(2):222-7. PubMed ID: 18421709
[TBL] [Abstract][Full Text] [Related]
11. Distribution of HER-2 overexpression in ovarian carcinoma tissue and its prognostic value in patients with ovarian carcinoma: from the Danish MALOVA Ovarian Cancer Study.
Høgdall EV; Christensen L; Kjaer SK; Blaakaer J; Bock JE; Glud E; Nørgaard-Pedersen B; Høgdall CK
Cancer; 2003 Jul; 98(1):66-73. PubMed ID: 12833457
[TBL] [Abstract][Full Text] [Related]
12. Elevated levels of chemokine receptor CXCR4 in HER-2 negative breast cancer specimens predict recurrence.
Holm NT; Byrnes K; Li BD; Turnage RH; Abreo F; Mathis JM; Chu QD
J Surg Res; 2007 Jul; 141(1):53-9. PubMed ID: 17574038
[TBL] [Abstract][Full Text] [Related]
13. Treatment algorithm for locally recurrent osteosarcoma based on local disease-free interval and the presence of lung metastasis.
Nathan SS; Gorlick R; Bukata S; Chou A; Morris CD; Boland PJ; Huvos AG; Meyers PA; Healey JH
Cancer; 2006 Oct; 107(7):1607-16. PubMed ID: 16933325
[TBL] [Abstract][Full Text] [Related]
14. Dynamic magnetic resonance imaging of regional contrast access as an additional prognostic factor in pediatric osteosarcoma.
Reddick WE; Wang S; Xiong X; Glass JO; Wu S; Kaste SC; Pratt CB; Meyer WH; Fletcher BD
Cancer; 2001 Jun; 91(12):2230-7. PubMed ID: 11413510
[TBL] [Abstract][Full Text] [Related]
15. The expression of CRM1 is associated with prognosis in human osteosarcoma.
Yao Y; Dong Y; Lin F; Zhao H; Shen Z; Chen P; Sun YJ; Tang LN; Zheng SE
Oncol Rep; 2009 Jan; 21(1):229-35. PubMed ID: 19082467
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of the HER-2 oncogene does not play a role in high-grade osteosarcomas.
Anninga JK; van de Vijver MJ; Cleton-Jansen AM; Kristel PM; Taminiau AH; Nooij M; Egeler RM; Hogendoorn PC
Eur J Cancer; 2004 May; 40(7):963-70. PubMed ID: 15093570
[TBL] [Abstract][Full Text] [Related]
17. HER-2 expression is not prognostic in osteosarcoma; a Children's Oncology Group prospective biology study.
Gorlick S; Barkauskas DA; Krailo M; Piperdi S; Sowers R; Gill J; Geller D; Randall RL; Janeway K; Schwartz C; Grier H; Meyers PA; Gorlick R; Bernstein M; Marina N
Pediatr Blood Cancer; 2014 Sep; 61(9):1558-64. PubMed ID: 24753182
[TBL] [Abstract][Full Text] [Related]
18. Post operative infection and increased survival in osteosarcoma patients: are they associated?
Jeys LM; Grimer RJ; Carter SR; Tillman RM; Abudu A
Ann Surg Oncol; 2007 Oct; 14(10):2887-95. PubMed ID: 17653803
[TBL] [Abstract][Full Text] [Related]
19. Effect of c-erbB2 overexpression on prognosis in osteosarcoma: evidence from eight studies.
Liu Y; Ma YH; Sun ZZ; Rui YJ; Yin QD; Song S; Wei XM; Liu J; Liu XG; Hu KJ
Tumour Biol; 2014 Sep; 35(9):8939-43. PubMed ID: 24899264
[TBL] [Abstract][Full Text] [Related]
20. Association of HER-2 overexpression with prognosis in nonsmall cell lung carcinoma: a metaanalysis.
Nakamura H; Kawasaki N; Taguchi M; Kabasawa K
Cancer; 2005 May; 103(9):1865-73. PubMed ID: 15770690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
